317 related articles for article (PubMed ID: 33130104)
1. Evaluating Responses to Gluten Challenge: A Randomized, Double-Blind, 2-Dose Gluten Challenge Trial.
Leonard MM; Silvester JA; Leffler D; Fasano A; Kelly CP; Lewis SK; Goldsmith JD; Greenblatt E; Kwok WW; McAuliffe WJ; Galinsky K; Siegelman J; Chow IT; Wagner JA; Sapone A; Smithson G
Gastroenterology; 2021 Feb; 160(3):720-733.e8. PubMed ID: 33130104
[TBL] [Abstract][Full Text] [Related]
2. HLA-DQ:gluten tetramer test in blood gives better detection of coeliac patients than biopsy after 14-day gluten challenge.
Sarna VK; Skodje GI; Reims HM; Risnes LF; Dahal-Koirala S; Sollid LM; Lundin KEA
Gut; 2018 Sep; 67(9):1606-1613. PubMed ID: 28779027
[TBL] [Abstract][Full Text] [Related]
3. HLA-DQ-Gluten Tetramer Blood Test Accurately Identifies Patients With and Without Celiac Disease in Absence of Gluten Consumption.
Sarna VK; Lundin KEA; Mørkrid L; Qiao SW; Sollid LM; Christophersen A
Gastroenterology; 2018 Mar; 154(4):886-896.e6. PubMed ID: 29146521
[TBL] [Abstract][Full Text] [Related]
4. A bispecific antibody targeting HLA-DQ2.5-gluten peptides potently blocks gluten-specific T cells induced by gluten ingestion in patients with celiac disease.
Hardy MY; Henneken LM; Russell AK; Okura Y; Mizoroki A; Ozono Y; Kobayashi S; Murakami Y; Tye-Din JA
Clin Immunol; 2024 Jul; 264():110259. PubMed ID: 38768856
[TBL] [Abstract][Full Text] [Related]
5. Gluten-Free Diet Induces Rapid Changes in Phenotype and Survival Properties of Gluten-Specific T Cells in Celiac Disease.
Risnes LF; Reims HM; Doyle RM; Qiao SW; Sollid LM; Lundin KEA; Christophersen A
Gastroenterology; 2024 Jul; 167(2):250-263. PubMed ID: 38552723
[TBL] [Abstract][Full Text] [Related]
6. Ex-vivo whole blood secretion of interferon (IFN)-γ and IFN-γ-inducible protein-10 measured by enzyme-linked immunosorbent assay are as sensitive as IFN-γ enzyme-linked immunospot for the detection of gluten-reactive T cells in human leucocyte antigen (HLA)-DQ2·5(+) -associated coeliac disease.
Ontiveros N; Tye-Din JA; Hardy MY; Anderson RP
Clin Exp Immunol; 2014 Feb; 175(2):305-15. PubMed ID: 24192268
[TBL] [Abstract][Full Text] [Related]
7. Assessing possible celiac disease by an HLA-DQ2-gliadin Tetramer Test.
Brottveit M; Ráki M; Bergseng E; Fallang LE; Simonsen B; Løvik A; Larsen S; Løberg EM; Jahnsen FL; Sollid LM; Lundin KE
Am J Gastroenterol; 2011 Jul; 106(7):1318-24. PubMed ID: 21364548
[TBL] [Abstract][Full Text] [Related]
8. Epitope-Specific Immunotherapy Targeting CD4-Positive T Cells in Celiac Disease: Safety, Pharmacokinetics, and Effects on Intestinal Histology and Plasma Cytokines with Escalating Dose Regimens of Nexvax2 in a Randomized, Double-Blind, Placebo-Controlled Phase 1 Study.
Daveson AJM; Ee HC; Andrews JM; King T; Goldstein KE; Dzuris JL; MacDougall JA; Williams LJ; Treohan A; Cooreman MP; Anderson RP
EBioMedicine; 2017 Dec; 26():78-90. PubMed ID: 29191561
[TBL] [Abstract][Full Text] [Related]
9. A Sensitive Whole Blood Assay Detects Antigen-Stimulated Cytokine Release From CD4+ T Cells and Facilitates Immunomonitoring in a Phase 2 Clinical Trial of Nexvax2 in Coeliac Disease.
Hardy MY; Goel G; Russell AK; Chen Yi Mei SLG; Brown GJE; Wang S; Szymczak E; Zhang R; Goldstein KE; Neff KM; Williams LJ; Truitt KE; Dzuris JL; Tye-Din JA; Anderson RP
Front Immunol; 2021; 12():661622. PubMed ID: 34093551
[TBL] [Abstract][Full Text] [Related]
10. CD38 expression on gluten-specific T cells is a robust marker of gluten re-exposure in coeliac disease.
Zühlke S; Risnes LF; Dahal-Koirala S; Christophersen A; Sollid LM; Lundin KE
United European Gastroenterol J; 2019 Dec; 7(10):1337-1344. PubMed ID: 31839959
[TBL] [Abstract][Full Text] [Related]
11. Pathogenic T Cells in Celiac Disease Change Phenotype on Gluten Challenge: Implications for T-Cell-Directed Therapies.
Christophersen A; Zühlke S; Lund EG; Snir O; Dahal-Koirala S; Risnes LF; Jahnsen J; Lundin KEA; Sollid LM
Adv Sci (Weinh); 2021 Nov; 8(21):e2102778. PubMed ID: 34495570
[TBL] [Abstract][Full Text] [Related]
12. Epitope-specific immunotherapy targeting CD4-positive T cells in coeliac disease: two randomised, double-blind, placebo-controlled phase 1 studies.
Goel G; King T; Daveson AJ; Andrews JM; Krishnarajah J; Krause R; Brown GJE; Fogel R; Barish CF; Epstein R; Kinney TP; Miner PB; Tye-Din JA; Girardin A; Taavela J; Popp A; Sidney J; Mäki M; Goldstein KE; Griffin PH; Wang S; Dzuris JL; Williams LJ; Sette A; Xavier RJ; Sollid LM; Jabri B; Anderson RP
Lancet Gastroenterol Hepatol; 2017 Jul; 2(7):479-493. PubMed ID: 28506538
[TBL] [Abstract][Full Text] [Related]
13. T-cell response to gluten in patients with HLA-DQ2.2 reveals requirement of peptide-MHC stability in celiac disease.
Bodd M; Kim CY; Lundin KE; Sollid LM
Gastroenterology; 2012 Mar; 142(3):552-61. PubMed ID: 22108197
[TBL] [Abstract][Full Text] [Related]
14. Plasma Cells Are the Most Abundant Gluten Peptide MHC-expressing Cells in Inflamed Intestinal Tissues From Patients With Celiac Disease.
Høydahl LS; Richter L; Frick R; Snir O; Gunnarsen KS; Landsverk OJB; Iversen R; Jeliazkov JR; Gray JJ; Bergseng E; Foss S; Qiao SW; Lundin KEA; Jahnsen J; Jahnsen FL; Sandlie I; Sollid LM; Løset GÅ
Gastroenterology; 2019 Apr; 156(5):1428-1439.e10. PubMed ID: 30593798
[TBL] [Abstract][Full Text] [Related]
15. TAK-101 Nanoparticles Induce Gluten-Specific Tolerance in Celiac Disease: A Randomized, Double-Blind, Placebo-Controlled Study.
Kelly CP; Murray JA; Leffler DA; Getts DR; Bledsoe AC; Smithson G; First MR; Morris A; Boyne M; Elhofy A; Wu TT; Podojil JR; Miller SD;
Gastroenterology; 2021 Jul; 161(1):66-80.e8. PubMed ID: 33722583
[TBL] [Abstract][Full Text] [Related]
16. Tetramer visualization of gut-homing gluten-specific T cells in the peripheral blood of celiac disease patients.
Ráki M; Fallang LE; Brottveit M; Bergseng E; Quarsten H; Lundin KE; Sollid LM
Proc Natl Acad Sci U S A; 2007 Feb; 104(8):2831-6. PubMed ID: 17307878
[TBL] [Abstract][Full Text] [Related]
17. A prospective, double-blind, placebo-controlled trial to establish a safe gluten threshold for patients with celiac disease.
Catassi C; Fabiani E; Iacono G; D'Agate C; Francavilla R; Biagi F; Volta U; Accomando S; Picarelli A; De Vitis I; Pianelli G; Gesuita R; Carle F; Mandolesi A; Bearzi I; Fasano A
Am J Clin Nutr; 2007 Jan; 85(1):160-6. PubMed ID: 17209192
[TBL] [Abstract][Full Text] [Related]
18. Glutenase ALV003 attenuates gluten-induced mucosal injury in patients with celiac disease.
Lähdeaho ML; Kaukinen K; Laurila K; Vuotikka P; Koivurova OP; Kärjä-Lahdensuu T; Marcantonio A; Adelman DC; Mäki M
Gastroenterology; 2014 Jun; 146(7):1649-58. PubMed ID: 24583059
[TBL] [Abstract][Full Text] [Related]
19. Safety and efficacy of AMG 714 in adults with coeliac disease exposed to gluten challenge: a phase 2a, randomised, double-blind, placebo-controlled study.
Lähdeaho ML; Scheinin M; Vuotikka P; Taavela J; Popp A; Laukkarinen J; Koffert J; Koivurova OP; Pesu M; Kivelä L; Lovró Z; Keisala J; Isola J; Parnes JR; Leon F; Mäki M
Lancet Gastroenterol Hepatol; 2019 Dec; 4(12):948-959. PubMed ID: 31494096
[TBL] [Abstract][Full Text] [Related]
20. Gliadin Nanoparticles Induce Immune Tolerance to Gliadin in Mouse Models of Celiac Disease.
Freitag TL; Podojil JR; Pearson RM; Fokta FJ; Sahl C; Messing M; Andersson LC; Leskinen K; Saavalainen P; Hoover LI; Huang K; Phippard D; Maleki S; King NJC; Shea LD; Miller SD; Meri SK; Getts DR
Gastroenterology; 2020 May; 158(6):1667-1681.e12. PubMed ID: 32032584
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
